THIOCARZOLAMIDE (NSC-45409): A PHASE I STUDY.
D000970:Antineoplastic Agents; D001247:Asthenia; D009325:Nausea; D009369:Neoplasms / Q000628:therapy*; D014116:Toxicology; D014839:Vomiting
D000970:Antineoplastic Agents
ANTINEOPLASTIC AGENTS; ASTHENIA; NAUSEA; NEOPLASM THERAPY; TOXICOLOGIC REPORT; VOMITING